DD137933A5 - Verfahren zur herstellung von neuen imidazo-isochinolin-dionen - Google Patents

Verfahren zur herstellung von neuen imidazo-isochinolin-dionen

Info

Publication number
DD137933A5
DD137933A5 DD78206810A DD20681078A DD137933A5 DD 137933 A5 DD137933 A5 DD 137933A5 DD 78206810 A DD78206810 A DD 78206810A DD 20681078 A DD20681078 A DD 20681078A DD 137933 A5 DD137933 A5 DD 137933A5
Authority
DD
German Democratic Republic
Prior art keywords
isochinolin
diones
preparing new
new imidazo
imidazo
Prior art date
Application number
DD78206810A
Other languages
German (de)
English (en)
Inventor
Volkhard Austel
Eberhard Kutter
Joachim Heider
Wolfgang Eberlein
Walter Kobinger
Christian Lillie
Willi Diederen
Walter Haarmann
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772732951 external-priority patent/DE2732951A1/de
Priority claimed from DE2732906A external-priority patent/DE2732906C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DD137933A5 publication Critical patent/DD137933A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD78206810A 1977-07-21 1978-07-19 Verfahren zur herstellung von neuen imidazo-isochinolin-dionen DD137933A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772732951 DE2732951A1 (de) 1977-07-21 1977-07-21 Neue imidazo-isochinolin-dione
DE2732906A DE2732906C2 (de) 1977-07-21 1977-07-21 In 5-Stellung durch einen Aminoalkylrest substituierte Imidazo-isochinolin-dione, Verfahren zu ihrer Herstellung und Arzneimittel

Publications (1)

Publication Number Publication Date
DD137933A5 true DD137933A5 (de) 1979-10-03

Family

ID=25772367

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78206810A DD137933A5 (de) 1977-07-21 1978-07-19 Verfahren zur herstellung von neuen imidazo-isochinolin-dionen

Country Status (29)

Country Link
US (1) US4176184A (no)
JP (1) JPS5422400A (no)
AT (1) AT366383B (no)
AU (1) AU519769B2 (no)
BG (1) BG30021A3 (no)
CA (1) CA1091232A (no)
CH (1) CH642367A5 (no)
CS (1) CS204032B2 (no)
DD (1) DD137933A5 (no)
DK (1) DK323378A (no)
ES (4) ES471254A1 (no)
FI (1) FI64371C (no)
FR (1) FR2398069A1 (no)
GB (1) GB2002751B (no)
GR (1) GR65025B (no)
HK (1) HK20685A (no)
HU (1) HU181000B (no)
IL (1) IL55168A (no)
IT (1) IT1107653B (no)
LU (1) LU80001A1 (no)
NL (1) NL7807760A (no)
NO (1) NO149314C (no)
NZ (1) NZ187916A (no)
PL (1) PL110398B1 (no)
PT (1) PT68329A (no)
SE (1) SE441746B (no)
SG (1) SG185G (no)
SU (1) SU688129A3 (no)
YU (1) YU40340B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2558707Y2 (ja) * 1986-06-25 1998-01-14 松下電工 株式会社 蓄積式防排煙受信機
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE19918211A1 (de) 1999-04-22 2000-10-26 Basf Ag Cycloalkylsubstituierte Benzimidazole, deren Herstellung und Anwendung
US6506769B2 (en) * 1999-10-06 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
DE60014130T2 (de) * 1999-10-06 2006-03-09 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Heterocyclische verbindungen verwendbar als tyrosinkinase inhibitoren
WO2002014319A2 (en) * 2000-08-11 2002-02-21 Boehringer Ingelheim Pharmaceuticals, Inc. Heterocyclic compounds useful as inhibitors of tyrosine kinases
CA2541618C (en) * 2003-10-30 2011-12-13 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368009B (no) * 1971-09-16 1974-06-17 Kabi Ab
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
US3878206A (en) * 1973-06-06 1975-04-15 Morton Norwich Products Inc 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines

Also Published As

Publication number Publication date
AT366383B (de) 1982-04-13
IT1107653B (it) 1985-11-25
FI64371B (fi) 1983-07-29
AU519769B2 (en) 1981-12-24
IL55168A (en) 1981-09-13
NO782498L (no) 1979-01-23
PT68329A (de) 1978-08-01
PL208543A1 (pl) 1979-05-21
AU3821078A (en) 1980-01-24
LU80001A1 (de) 1979-09-06
ES476168A1 (es) 1979-05-16
SE441746B (sv) 1985-11-04
GR65025B (en) 1980-06-16
NZ187916A (en) 1981-05-01
SE7808018L (sv) 1979-01-22
NO149314C (no) 1984-03-28
JPS6112912B2 (no) 1986-04-10
GB2002751B (en) 1982-02-10
PL110398B1 (en) 1980-07-31
SG185G (en) 1985-06-14
FR2398069A1 (fr) 1979-02-16
NL7807760A (nl) 1979-01-23
NO149314B (no) 1983-12-19
HK20685A (en) 1985-03-29
JPS5422400A (en) 1979-02-20
ES471254A1 (es) 1979-10-01
ES476166A1 (es) 1979-06-01
IL55168A0 (en) 1978-09-29
BG30021A3 (en) 1981-03-16
YU40340B (en) 1985-12-31
YU174778A (en) 1983-02-28
IT7850337A0 (it) 1978-07-17
CH642367A5 (de) 1984-04-13
CS204032B2 (en) 1981-03-31
DK323378A (da) 1979-01-22
ATA498878A (de) 1981-08-15
HU181000B (en) 1983-05-30
SU688129A3 (ru) 1979-09-25
ES476167A1 (es) 1979-04-16
FI64371C (fi) 1983-11-10
US4176184A (en) 1979-11-27
CA1091232A (en) 1980-12-09
FR2398069B1 (no) 1981-05-22
GB2002751A (en) 1979-02-28
FI782011A (fi) 1979-01-22

Similar Documents

Publication Publication Date Title
AT372093B (de) Verfahren zur herstellung von neuen corticoid-17- alkylcarbonaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
LU79212A1 (de) Verfahren zur herstellung von neuen 4-acylamino-phenylaethanolaminen
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT371455B (de) Verfahren zur herstellung von neuen prostanderivaten
AT368753B (de) Verfahren zur herstellung von neuen azacycloalkanen
AT361455B (de) Verfahren zur herstellung von neuen substituierten 3-phenyl-cycloalkan- oder - -cycloalken-1-olen
AT368137B (de) Verfahren zur herstellung von neuen 4-amino-5alkylthiopyrimidinen
AT366368B (de) Verfahren zur herstellung von neuen chinolylguanidinen
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
AT361622B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosid-anitbiotika
DD137933A5 (de) Verfahren zur herstellung von neuen imidazo-isochinolin-dionen
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT357677B (de) Verfahren zur herstellung von neuen azacyclyl- -verbindungen
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT372690B (de) Verfahren zur herstellung von neuen polyhydantoinen
AT360676B (de) Verfahren zur herstellung von neuen 17beta- -hydroxy-4-androsten-3-onen
ATA750578A (de) Verfahren zur herstellung von neuen pyridothiazo- linen
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT372954B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
ATA664076A (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
ATA89776A (de) Verfahren zur herstellung von neuen 1-methyl-3-alkyl-7-oxoalkylxanthinen
AT363473B (de) Verfahren zur herstellung von neuen 4-hydroxy-thiazolidin-2-thion-derivaten
ATA893877A (de) Verfahren zur herstellung von neuen 3-din- -propylacetoxybenzodiazepin-2-onen